Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 20th Street, Suite 150
Pacific Brain Health Center, Pacific Neuroscience Institute
Santa Monica, CA 90404Phone+1 310-582-7641
Summary
- Dr. Verna Porter is a neurologist in Santa Monica, CA and is affiliated with multiple hospitals in the area, including UCLA Medical Center-Santa Monica, Ronald Reagan UCLA Medical Center, Providence Saint John's Health Center, and Providence Saint John's Health Center. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 23 years. She is experienced in general neurology, alzheimer's disease, and behavioral neurology / neuropsychiatry.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1995 - 1998
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1994 - 1995
- David Geffen School of Medicine at UCLAClass of 1994
Certifications & Licensure
- CA State Medical License 1995 - 2025
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 19 citationsMGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids.Milan Fiala, Michelle Mahanian, Mark Rosenthal, Matthew T Mizwicki, Eric Tse
Journal of Alzheimer's Disease. 2011-01-01 - 18 citationsOmega-3 Fatty Acids Increase the Unfolded Protein Response and Improve Amyloid-β Phagocytosis by Macrophages of Patients With Mild Cognitive ImpairmentHenry M. Olivera-Perez, Larry Lam, Johnny Dang, Weilan Jiang, Fabian Rodriguez
FASEB Journal. 2017-06-20 - 55 citationsω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairmentMilan Fiala, Ramesh C. Halder, Bien Sagong, Olivia Ross, James Sayre
FASEB Journal. 2015-03-24
Press Mentions
- Daytime Sleepiness May Be a Sign of Higher Dementia RiskNovember 7th, 2024
- Ozempic Could Cut Alzheimer's Risk by a Whopping 70 Percent, New Research FindsOctober 28th, 2024
- Semaglutide Drugs May Help Keep Alzheimer's at BayOctober 24th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: